Low-dose combination therapy of severe digital ulcers in diffuse progressive systemic sclerosis with the endothelin-1 receptor antagonist bosentan and the phosphodiesterase v inhibitor sildenafil;Niedrig-dosis-kombinationstherapie Schwerster Digitaler Ulzerationen bei Diffuser Progressiver Systemischer Sklerodermie mit dem Endothelin-1- Rezeptor-Antagonisten Bosentan und dem Phosphodiesterase-VInhibitor Sildenafil

JDDG - Journal of the German Society of Dermatology

Volumn 7, Issue 10, 2009, Pages 888-892

  Ambach, Andreas ^a   Seo, Won ^a   Bonnekoh, Bernd ^a   Gollnick, Harald ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Bosentan; Digital ulcers; Sildenafil; Systemic sclerosis

Indexed keywords

AMINOTRANSFERASE; ANTINUCLEAR ANTIBODY; AZATHIOPRINE; BOSENTAN; ILOPROST; ISOSORBIDE DINITRATE; METHYLPREDNISOLONE; NIFEDIPINE; PENTOXIFYLLINE; RAMIPRIL; RHEUMATOID FACTOR; SILDENAFIL;

ADD ON THERAPY; AGED; AMINOTRANSFERASE BLOOD LEVEL; ANAMNESIS; ANOREXIA; ARTHRALGIA; ARTICLE; CACHEXIA; CASE REPORT; CATARACT; CLINICAL ASSESSMENT; CORTICOSTEROID THERAPY; DIGITAL ULCER; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG POTENTIATION; DRUG SAFETY; DYSPHAGIA; DYSPNEA; FEMALE; FINGER; FLEXION CONTRACTURE; FOREARM; HEADACHE; HOT FLUSH; HUMAN; LABORATORY TEST; LONG TERM CARE; LOW DRUG DOSE; LUNG FIBROSIS; RAYNAUD PHENOMENON; SCINTIGRAPHY; SIDE EFFECT; SKIN EDEMA; SKIN SWELLING; SKIN ULCER; SYSTEMIC SCLEROSIS; TELANGIECTASIA; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; ULCER; ULCER HEALING;

AGED; DRUG THERAPY, COMBINATION; FEMALE; FINGERS; HAND DERMATOSES; HUMANS; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; PURINES; RECEPTORS, ENDOTHELIN; SCLERODERMA, DIFFUSE; SULFONAMIDES; SULFONES; TREATMENT OUTCOME; ULCER;

EID: 70349917619     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/j.1610-0387.2009.07057.x     Document Type: Article

References (12)

1. Chung L. Therapeutic options for digital ulcers in patients with systemic sclerosis. J Dtsch Dermatol Ges 2007 5 : 460 465.
2. Liu C, Chen J. Endothelin receptor antagonists for pulmonary arterial hypertension. Cochrane Database Syst Rev 2006 3 : CD004434.
3. Yamane K, Miyauchi T, Suzuki N, Yuhara T, Akama T, Suzuki H, Kashiwagi H. Significance of plasma endothelin-1 levels in patients with systemic sclerosis. J Rheumatol 1992 19 : 1566 1571.
4. Korn JH, Mayes M, Matucci Cerinic M, Rainisio M, Pope J, Hachulla E, Rich E, Carpentier P, Molitor J, Seibold JR, Hsu V, Guillevin L, Chatterjee S, Peter HH, Coppock J, Herrick A, Merkel PA, Simms R, Denton CP, Furst D, Nguyen N, Gaitonde M, Black C. Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist. Arthritis Rheum 2004 50 : 3985 3993.
5. Siebold J. Bosentan prevents occurrence but does not speed the healing of digital ulcers in patients with systemic sclerosis. Arthritis Rheum 2005 L2 : 552 (Abstract).
6. Galiè N, Ghofrani HA, Torbicki A, Barst RJ, Rubin LJ, Badesch D, Fleming T, Parpia T, Burgess G, Branzi A, Grimminger F, Kurzyna M, Simonneau G. Sildenafil citrate therapy for pulmonary arterial hypertension. NEJM 2006 354 : 2400 2401.
7. Rosenkranz S, Diet F, Karasch T, Weihrauch J, Wassermann K, Erdmann E. Sildenafil improved pulmonary hypertension and peripheral blood flow in a patient with scleroderma-associated lung fibrosis and the raynaud phenomenon. Ann Int. Med 2003 139 : 871 873.
8. Colglazier CL, Sutej PG, O'Rourke KS. Severe refractory fingertip ulcerations in a patient with scleroderma: successful treatment with sildenafil. J Rheumatol 2005 32 : 2440 2442.
9. Hoeper MM, Faulenbach C, Golpon H, Winkler J, Welte T, Niedermeyer J. Combination therapy with bosentan and sildenafil in idiopathic pulmonary arterial hypertension. Eur Respir J 2004 24 : 1007 1010.
10. Lunze K, Gilbert N, Mebus S, Miera O, Fehske W, Uhlemann F, Mühler EG, Ewert P, Lange PE, Berger F, Schulze-Neick I. First experience with an oral combination therapy using bosentan and sildenafil for pulmonary arterial hypertension. Eur J Clin Invest 2006 36 Suppl 3 : 32 38.
11. Austin MJ, McDougall NI, Wendon JA, Sizer E, Knisely AS, Rela M, Wilson C, Callender ME, O'Grady JG, Heneghan MA. Safety and efficacy of combined use of sildenafil, bosentan, and iloprost before and after liver transplantation in severe portopulmonary hypertension. Liver Transpl 2008 14 : 287 291.
12. Catapano-Minotti G, Corsonello A, Guadalupi G, Spani R, Antonelli-Incalzi R. Treatment of severe pulmonary hypertension secondary to scleroderma: a three-drug approach. Intern Med 2008 47 : 511 513.